XATRAL SR 10mg prolonged tablets medication leaflet

G04CA01 alfuzosin • Genito urinary system and sex hormones | Drugs used in benign prostatic hypertrophy | Alpha-adrenoreceptor antagonists

Alfuzosin is a medication used to treat symptoms associated with benign prostatic hyperplasia (BPH), a condition characterized by an enlarged prostate that can cause difficulty urinating. Alfuzosin belongs to the class of alpha-blockers and works by relaxing the smooth muscles in the prostate and bladder neck, making it easier to urinate.

It is taken orally, usually once daily after a meal, to reduce the risk of side effects. Beneficial effects may be noticed within a few days of starting treatment.

Common side effects include dizziness, fatigue, headache, or orthostatic hypotension (a drop in blood pressure when standing up). Patients are advised to avoid sudden movements to prevent dizziness. Alfuzosin is contraindicated in patients with severe liver impairment or those taking other medications that may interact with it. It should be used as directed by a doctor.

General data about XATRAL SR 10mg

Substance: alfuzosin

Date of last drug list: 01-06-2025

Commercial code: W62086003

Concentration: 10mg

Pharmaceutical form: prolonged tablets

Quantity: 30

Product type: original

Price: 40.93 RON

Prescription restrictions: P-6L - Medicines prescription that isn't retained in the pharmacy (can be renewed); the prescription can be used for 6 months from the moment of release.

Marketing authorisation

Manufacturer: SANOFI WINTHROP INDUSTRIE - FRANTA

Holder: SANOFI ROMANIA S.R.L. - ROMANIA

Number: 11628/2019/02

Shelf life: 3 years

Pharmaceutical forms available for alfuzosin

Concentrations available for alfuzosin

10mg, 2.5mg, 5mg

Other substances similar to alfuzosin

Compensation lists for XATRAL SR 10mg SANOFI

B - Sublist B with 50% discount from the reference price

Price

Copayment

Patient

40.93 RON

20.46 RON

20.47 RON